Structured Summary
Abstract
A thymus hormone polypeptide found in thymosin fraction 5 (a crude thymus gland extract) but now produced by synthesis. It is used alone or with interferon as an immunomodulator for the treatment of CHRONIC HEPATITIS B and HEPATITIS C. Thymalfasin is also used for the treatment of chemotherapy-induced immunosuppression, and to enhance the efficacy of influenza and hepatitis B vaccines in immunocompromised patients.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
5 entry terms
- Thymosin alpha(1)
- Thymosin alpha1
- alpha1-Thymosin
- alpha1 Thymosin
- Zadaxin
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2019 (1980)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Thymalfasin. Medical Subject Headings (MeSH). 2026. Unique ID D000077596. http://id.nlm.nih.gov/mesh/2026/D000077596
- Thymalfasin. In: Wikidata. https://www.wikidata.org/wiki/Q20817234